Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (17 papers)
-
Thrombolytic Agents: Clinical Trials Issues
-
Thrombolytic Agents: Adjunctive Issues
-
Risk vs. Benefit for Antiarrhythmic Drugs
-
Hypolipidemic Agents: Clinical & Regulatory Issues
Keywords
About this book
Editors and Affiliations
Bibliographic Information
Book Title: Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Book Subtitle: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Editors: Joel Morganroth, E. Neil Moore
Series Title: Developments in Cardiovascular Medicine
DOI: https://doi.org/10.1007/978-1-4613-1605-3
Publisher: Springer New York, NY
-
eBook Packages: Springer Book Archive
Copyright Information: Kluwer Academic Publishers 1989
Hardcover ISBN: 978-0-7923-0294-0Published: 30 June 1989
Softcover ISBN: 978-1-4612-8888-6Published: 10 October 2011
eBook ISBN: 978-1-4613-1605-3Published: 06 December 2012
Series ISSN: 0166-9842
Edition Number: 1
Number of Pages: XVIII, 298
Topics: Cardiology